Terminated PHASE1 INTERVENTIONAL 3-arm NCT03257592

Positron Emission Tomography (PET) Imaging of Glial Activation in Psychotic Disease States

PET Imaging of Glial Activation in Psychotic Disease States

Sponsor: Johns Hopkins University

Conditions Bipolar Disorder Schizophrenia

Updated 7 times since 2017 Last updated: Sep 8, 2020 Started: Aug 31, 2010 Primary completion: Apr 30, 2018 Completion: Apr 30, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Lack of funding

Other terminated trials from Johns Hopkins University

See all terminations from Johns Hopkins University

Other Bipolar Disorder trials with similar outcome

Browse all Bipolar Disorder trials

This PHASE1 trial investigates Bipolar Disorder and Schizophrenia and is currently terminated or withdrawn. Johns Hopkins University leads this study, which shows 7 recorded versions since 2010 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE1
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE1
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE1
Oct 2020 — Jan 2021 [monthly]

Terminated PHASE1
Nov 2018 — Oct 2020 [monthly]

Terminated PHASE1

Status: Active Not Recruiting → Terminated · Phase: NA → PHASE1

▶ Show 2 earlier versions

Jun 2018 — Nov 2018 [monthly]

Active Not Recruiting NA
Sep 2017 — Jun 2018 [monthly]

Active Not Recruiting NA

First recorded

Aug 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Johns Hopkins University

Data source: Johns Hopkins University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Baltimore, United States